What is Nuvation Bio's total equity?

Nuvation Bio (NUVB) reported total equity of $319.56M in Q1 2026.

How has Nuvation Bio's total equity changed year-over-year?

Nuvation Bio's total equity decreased by 23.8% year-over-year, from $419.46M to $319.56M.

What is the long-term trend for Nuvation Bio's total equity?

Over 5 years (2020 to 2025), Nuvation Bio's total equity has grown at a 7.3% compound annual growth rate (CAGR), from $215.08M to $305.72M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Nuvation Bio NUVB Total Equity

Total Equity at other companies

Bristol-Myers SquibbBMY

$20.07B+15.4%

PfizerPFE

$90.1B-0.3%

Nuvalent, Inc.NUVL

$1.17B+16.2%

ImmunomeIMNM

$588.69M+91.7%

ArriVent BioPharma, Inc.AVBP

$323.98M+60.0%

Arcus BiosciencesRCUS

$524M-1.3%

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's total equity?: Nuvation Bio (NUVB) reported total equity of $319.56M in Q1 2026.
How has Nuvation Bio's total equity changed year-over-year?: Nuvation Bio's total equity decreased by 23.8% year-over-year, from $419.46M to $319.56M.
What is the long-term trend for Nuvation Bio's total equity?: Over 5 years (2020 to 2025), Nuvation Bio's total equity has grown at a 7.3% compound annual growth rate (CAGR), from $215.08M to $305.72M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.